Sylvia E. Rosas, M.D., MSCE
Assistant Professor of Medicine
Department: Medicine
Contact information
Room 113
1 Founders Pavilion/HUP
3400 Spruce Street
Philadelphia, PA 19104
1 Founders Pavilion/HUP
3400 Spruce Street
Philadelphia, PA 19104
Office: 215-615-3446
Fax: 215-615-3447
Fax: 215-615-3447
Email:
sylvia.rosas@uphs.upenn.edu
sylvia.rosas@uphs.upenn.edu
Publications
Education:
M.D.
Colegio Mayor de Nuestra Senora del Rosario, Bogota, Columbia, 1990.
(Business Administration)
Wharton Management Program, University of Pennsylvania, 2002.
M.S.C.E. (Clinical Epidemiology and Biostatistics Program)
University of Pennsylvania, 2003.
Permanent linkM.D.
Colegio Mayor de Nuestra Senora del Rosario, Bogota, Columbia, 1990.
(Business Administration)
Wharton Management Program, University of Pennsylvania, 2002.
M.S.C.E. (Clinical Epidemiology and Biostatistics Program)
University of Pennsylvania, 2003.
Description of CVI Expertise
CVI Program Unit(s):Lipid / Atherosclerosis / CAD / ACS / Prevention
CVI Research Description:
Dr. Rosas's research focuses on examining the role of novel risk factors [for example, inflammatory markers, homocysteine, Lipoprotein(a)] in the development and progression of cardiovascular disease in patients with chronic kidney disease. Dr. Rosas is the principal investigator on several on going studies evaluating the use of non-invasive cardiovascular procedures such as electron beam computed tomography and carotid intima-media thickness in CKD patients (including dialysis and transplant recipients).
Selected Publications
Rosas SE, Feldman HI: Synthetic Vascular Hemodialysis Access vs Native Arteriovenous Fistula: A Cost-Utility Analysis. Annals of Surgery 255(1): 181-6, Jan 2012Wahl P, Xie H, Scialla J, Anderson CA, Bellovich K, Brecklin C, Chen J, Feldman H, Gutierrez OM, Lash J, Leonard MB, Negrea L, Rosas SE, Anderson AH, Townsend RR, Wolf M, Isakova T. : Earlier onset and greater severity of disordered mineral metabolism in diabetic patients with chronic kidney disease. Diabetes Care 2012.
Rosas SE, Reese PP. Huan Y, Doria C, Cochetti P, Doyle AM: Pre-transplant Physical Activity is a Predictor of All-Cause Mortality in Kidney Transplant Recipients. American Journal of Nephrology 35(1): 17-23 Dec 2011.
Scialla JJ, Leonard MB, Townsend RR, Appel L, Wolf M, Budoff MJ, Chen J, Lustigova E. Gadegbeku CA, Glenn M, Hanish A, Raj D, Rosas SE, Seliger SL, Weir MR, Parekh RS on behalf of the CRIC Study Group: Correlates of Osteoprotegerin and Association with Aortic Pulse Wave Velocity in Patients with Chronic Kidney Disease. Clinical Journal of the American Society of Nephrology 6(11): 2612-2619, Nov 2011.
Faul C*, Amaral AP*, Oskouei B*, Hu MC, Sloan A, Isakova T, Gutiérrez OM, Aguillon-Prada R, Lincoln J, Hare JM, Mundel P, Morales A, Scialla J, Fischer M, Soliman EZ, Chen J, Go AS, Rosas SE, Nessel L, Townsend RR, Feldman HI, St. John Sutton M, Ojo A, Gadegbeku C, Di Marco GS, Reuter S, Kentrup D, Tiemann K, Brand M, Hill JA, Moe OW, Kuro-o M, Kusek JW, Keane MG, Wolf M. *contributed equally : Fibroblast growth factor 23 induces left ventricular hypertrophy. Journal of Clinical Investigation 121(11): 4393-408, Nov 2011.
Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L, Gaziano M, Kasiske B, Walker R, Massy ZA, Feldt-Rasmusseb B, Krairittichai U, Ophascharoensuk V, Fellstrom B, Holdaas H, Tesar V, Wiecek A, Grobbee D, de Zeeuw D, gronhagen-Riska C, Dasgupta T, Lewis D, Herrington W, Mafham M, Majoni W, Wallendszus K, Grimm R, Pedersen T, Tobert J, Armitage J, Baxter A, Bray C, Chen Y, Chen Z, Hill M, Knott C, Parish S, Simpson D, Sleight P, Young A, Collins, R on behalf of the SHARP Investigators: The Effects of Lowering LDL Cholesterol with Simvastatin Plus Ezetimibe in Patientswith Chronic Kidney Disease (Study of Heart and Renal Protection): A randomized pacebo-controlled trial. The Lancet 377(9784): 2181-92, June 2011.
Day EC, Li Y, Diez-Roux A, Kandula N, Moran A, Rosas S, Shlipak MG, Peralta CA: Associations of acculturation and kidney dysfunction among Hispanics and Chinese from the Multi-Ethnic Study of Atherosclerosis (MESA). Nephrology, Dialysis and Transplantation 26(6): 1909-16, Jun 2011.
Bayer ND, Cochetti PT, Anil Kumar MS, Teal V, Huan Y, Doria C, Bloom RD, Rosas SE: Association of Metabolic Syndrome with Development of New Onset Diabetes After Transplantation. Transplantation 90(8): 861-866, October 2010 Notes: Featured article with commentary by Vanlaecke S, "The Metabolic Syndrome and New-Onset Diabetes After Transplantation: Presumed Guilty?" Transplantation October, 2010.
Roe P, Wolfe M, Joffe M, Rosas SE: Inflammation, Coronary Artery Calcification and Cardiovascular Events in Incident Renal Transplant Recipients. Atherosclerosis 212(2): 589-594 October 2010 Notes: Featured article with Commentary: Santos RD. "Coronary artery calcification progression and cardiovascular events in renal transplant recipients, bad inheritance from previous kidney disease: Commentary on the study of Roe" Atherosclerosis (2010) PMID 20619413.
Tan A, Hoffman B, Rosas SE: Patient Perception of Risk Factors Associated with Chronic Kidney Disease Morbidity and Mortality. Ethnicity and Disease 20(2): 106-10, Spring 2010.